A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1

מצבים רפואיים

Advanced Solid Tumor · Advanced Breast Cancer · Advanced Ovarian Cancer

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • University of Alabama at Birmingham, Birmingham, Alabama, United States

    Contact: Study coordinator (Mehmet Akce) · 205-975-0832
  • Providence St. Jude Medical Center, Fullerton, California, United States

    Contact: Study coordinator (Yung Lyou) · 714-446-5900
  • Marin Cancer Care, Greenbrae, California, United States

    Contact: Study coordinator (Cyrus Mazidi) · 415-925-5000
  • Moores Cancer Center, La Jolla, California, United States

    Contact: Study coordinator (Peter Vu) · 858-822-2463
  • Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States

    Contact: Study coordinator (Monica Mita) · 949-764-4060
  • Local Institution - 0008, Aurora, Colorado, United States

  • Dana-Farber Cancer Institute, Boston, Massachusetts, United States

    Contact: Study coordinator (Joyce Liu) · 617-632-5269
  • Washington University School of Medicine, St Louis, Missouri, United States

    Contact: Study coordinator (Faisal Fa'ak)
  • Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

    Contact: Study coordinator (Lionel Lewis) · 603-381-1953
  • Roswell Park Cancer Institute, Buffalo, New York, United States

    Contact: Study coordinator (Christos Fountzilas) · 716-845-4720
  • Northwell Health-Cancer Institute, New Hyde Park, New York, United States

    Contact: Study coordinator (Geraldine O'Sullivan Coyne)
  • Local Institution - 0011, New York, New York, United States

  • Memorial Sloan Kettering Cancer Center, New York, New York, United States

    Contact: Study coordinator (Ezra Rosen) · 000-000-0000
  • START Dallas Fort Worth, Fort Worth, Texas, United States

    Contact: Study coordinator (Henry Xiong) · 682-350-3010
  • NEXT Oncology, San Antonio, Texas, United States

    Contact: Study coordinator (David Sommerhalder) · 210-580-9500
  • Odense Universitetshospital, Odense, Region Syddanmark, Denmark

    Contact: Study coordinator (Annette Kodahl) · 004566113333
  • Copenhagen University Hospital, Copenhagen, Denmark

    Contact: Study coordinator (Martin Højgaard) · 4535456861
  • National Cancer Center Hospital East, Kashiwa, Chiba, Japan

    Contact: Study coordinator (Chikako Funasaka) · 81471331111
  • Kansai Medical University Hospital, Hirakata, Osaka, Japan

    Contact: Study coordinator (Toshio Shimizu) · +81728040101
  • National Cancer Center Hospital, Chuo-ku, Tokyo, Japan

    Contact: Study coordinator (Takafumi Koyama) · 81335422511
  • The Cancer Institute Hospital of JFCR, Koto-ku, Tokyo, Japan

    Contact: Study coordinator (Shigehisa Kitano) · 0335200111
מובילי המחקר
  • Bristol-Myers Squibb

    Study Director

    Bristol-Myers Squibb